Table of Contents Chapter 1 Overview of Insomnia Drugs 1.1 Definition of Insomnia Drugs in This Report 1.2 Commercial Types of Insomnia Drugs 1.2.1 Tablets 1.2.2 Capsules 1.3 Downstream Application of Insomnia Drugs 1.3.1 Adults 1.3.2 Children 1.4 Development History of Insomnia Drugs 1.5 Market Status and Trend of Insomnia Drugs 2013-2023 1.5.1 North America Insomnia Drugs Market Status and Trend 2013-2023 1.5.2 Regional Insomnia Drugs Market Status and Trend 2013-2023 Chapter 2 North America Market Status and Forecast by Regions 2.1 Market Status of Insomnia Drugs in North America 2013-2017 2.2 Consumption Market of Insomnia Drugs in North America by Regions 2.2.1 Consumption Volume of Insomnia Drugs in North America by Regions 2.2.2 Revenue of Insomnia Drugs in North America by Regions 2.3 Market Analysis of Insomnia Drugs in North America by Regions 2.3.1 Market Analysis of Insomnia Drugs in United States 2013-2017 2.3.2 Market Analysis of Insomnia Drugs in Canada 2013-2017 2.3.3 Market Analysis of Insomnia Drugs in Mexico 2013-2017 2.4 Market Development Forecast of Insomnia Drugs in North America 2018-2023 2.4.1 Market Development Forecast of Insomnia Drugs in North America 2018-2023 2.4.2 Market Development Forecast of Insomnia Drugs by Regions 2018-2023 Chapter 3 North America Market Status and Forecast by Types 3.1 Whole North America Market Status by Types 3.1.1 Consumption Volume of Insomnia Drugs in North America by Types 3.1.2 Revenue of Insomnia Drugs in North America by Types 3.2 North America Market Status by Types in Major Countries 3.2.1 Market Status by Types in United States 3.2.2 Market Status by Types in Canada 3.2.3 Market Status by Types in Mexico 3.3 Market Forecast of Insomnia Drugs in North America by Types Chapter 4 North America Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Insomnia Drugs in North America by Downstream Industry 4.2 Demand Volume of Insomnia Drugs by Downstream Industry in Major Countries 4.2.1 Demand Volume of Insomnia Drugs by Downstream Industry in United States 4.2.2 Demand Volume of Insomnia Drugs by Downstream Industry in Canada 4.2.3 Demand Volume of Insomnia Drugs by Downstream Industry in Mexico 4.3 Market Forecast of Insomnia Drugs in North America by Downstream Industry Chapter 5 Market Driving Factor Analysis of Insomnia Drugs 5.1 North America Economy Situation and Trend Overview 5.2 Insomnia Drugs Downstream Industry Situation and Trend Overview Chapter 6 Insomnia Drugs Market Competition Status by Major Players in North America 6.1 Sales Volume of Insomnia Drugs in North America by Major Players 6.2 Revenue of Insomnia Drugs in North America by Major Players 6.3 Basic Information of Insomnia Drugs by Major Players 6.3.1 Headquarters Location and Established Time of Insomnia Drugs Major Players 6.3.2 Employees and Revenue Level of Insomnia Drugs Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Insomnia Drugs Major Manufacturers Introduction and Market Data 7.1 Eisai 7.1.1 Company profile 7.1.2 Representative Insomnia Drugs Product 7.1.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Eisai 7.2 Merck 7.2.1 Company profile 7.2.2 Representative Insomnia Drugs Product 7.2.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Merck 7.3 Pfizer 7.3.1 Company profile 7.3.2 Representative Insomnia Drugs Product 7.3.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Pfizer 7.4 Sanofi 7.4.1 Company profile 7.4.2 Representative Insomnia Drugs Product 7.4.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Sanofi 7.5 Takeda 7.5.1 Company profile 7.5.2 Representative Insomnia Drugs Product 7.5.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Takeda 7.6 Astellas 7.6.1 Company profile 7.6.2 Representative Insomnia Drugs Product 7.6.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Astellas 7.7 Biocodex 7.7.1 Company profile 7.7.2 Representative Insomnia Drugs Product 7.7.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Biocodex 7.8 Dainippon Sumitomo 7.8.1 Company profile 7.8.2 Representative Insomnia Drugs Product 7.8.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Dainippon Sumitomo 7.9 ECR Pharmaceuticals 7.9.1 Company profile 7.9.2 Representative Insomnia Drugs Product 7.9.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of ECR Pharmaceuticals 7.10 Fidia Farmaceutici 7.10.1 Company profile 7.10.2 Representative Insomnia Drugs Product 7.10.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Fidia Farmaceutici 7.11 Flynn Pharma 7.11.1 Company profile 7.11.2 Representative Insomnia Drugs Product 7.11.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Flynn Pharma 7.12 Johnson & Johnson 7.12.1 Company profile 7.12.2 Representative Insomnia Drugs Product 7.12.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 7.13 Juste 7.13.1 Company profile 7.13.2 Representative Insomnia Drugs Product 7.13.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Juste 7.14 Meda 7.14.1 Company profile 7.14.2 Representative Insomnia Drugs Product 7.14.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Meda 7.15 Pernix Therapeutics 7.15.1 Company profile 7.15.2 Representative Insomnia Drugs Product 7.15.3 Insomnia Drugs Sales, Revenue, Price and Gross Margin of Pernix Therapeutics 7.16 Purdue Pharma 7.17 Vanda Pharmaceuticals Chapter 8 Upstream and Downstream Market Analysis of Insomnia Drugs 8.1 Industry Chain of Insomnia Drugs 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Insomnia Drugs 9.1 Cost Structure Analysis of Insomnia Drugs 9.2 Raw Materials Cost Analysis of Insomnia Drugs 9.3 Labor Cost Analysis of Insomnia Drugs 9.4 Manufacturing Expenses Analysis of Insomnia Drugs Chapter 10 Marketing Status Analysis of Insomnia Drugs 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Tablets Table Advantage and Disadvantage of Capsules Table Consumption Volume of Insomnia Drugs in North America by Regions 2013-2017 Table Revenue of Insomnia Drugs in North America by Regions 2013-2017 Table Consumption Volume of Insomnia Drugs in North America by Regions 2018-2023 Table Revenue of Insomnia Drugs in North America by Regions 2018-2023 Table Consumption Volume of Insomnia Drugs in North America by Types 2013-2017 Table Revenue of Insomnia Drugs in North America by Types 2013-2017 Table Consumption Volume of Insomnia Drugs by Types in United States 2013-2017 Table Consumption Volume of Insomnia Drugs by Types in Canada 2013-2017 Table Consumption Volume of Insomnia Drugs by Types in Mexico 2013-2017 Table Consumption Volume Forecast of Insomnia Drugs in North America by Types 2018-2023 Table Revenue Forecast of Insomnia Drugs in North America by Types 2018-2023 Table Demand Volume of Insomnia Drugs in North America by Downstream Industry 2013-2017 Table Demand Volume of Insomnia Drugs by Downstream Industry in United States 2013-2017 Table Demand Volume of Insomnia Drugs by Downstream Industry in Canada 2013-2017 Table Demand Volume of Insomnia Drugs by Downstream Industry in Mexico 2013-2017 Table Demand Volume Forecast of Insomnia Drugs in North America by Downstream Industry 2018-2023 Table Sales Volume of Insomnia Drugs in North America by Major Players 2013-2017 Table Revenue of Insomnia Drugs in North America by Major Players 2013-2017 Table Headquarters Location and Established Time of Insomnia Drugs Major Players Table Employees and Revenue Level of Insomnia Drugs Major Players Table Representative Insomnia Drugs Product One of Eisai Table Representative Insomnia Drugs Product Two of Eisai Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Eisai 2013-2017 Table Representative Insomnia Drugs Product One of Merck Table Representative Insomnia Drugs Product Two of Merck Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Insomnia Drugs Product One of Pfizer Table Representative Insomnia Drugs Product Two of Pfizer Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Insomnia Drugs Product One of Sanofi Table Representative Insomnia Drugs Product Two of Sanofi Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017 Table Representative Insomnia Drugs Product One of Takeda Table Representative Insomnia Drugs Product Two of Takeda Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Takeda 2013-2017 Table Representative Insomnia Drugs Product One of Astellas Table Representative Insomnia Drugs Product Two of Astellas Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Astellas 2013-2017 Table Representative Insomnia Drugs Product One of Biocodex Table Representative Insomnia Drugs Product Two of Biocodex Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Biocodex 2013-2017 Table Representative Insomnia Drugs Product One of Dainippon Sumitomo Table Representative Insomnia Drugs Product Two of Dainippon Sumitomo Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Dainippon Sumitomo 2013-2017 Table Representative Insomnia Drugs Product One of ECR Pharmaceuticals Table Representative Insomnia Drugs Product Two of ECR Pharmaceuticals Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of ECR Pharmaceuticals 2013-2017 Table Representative Insomnia Drugs Product One of Fidia Farmaceutici Table Representative Insomnia Drugs Product Two of Fidia Farmaceutici Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Fidia Farmaceutici 2013-2017 Table Representative Insomnia Drugs Product One of Flynn Pharma Table Representative Insomnia Drugs Product Two of Flynn Pharma Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Flynn Pharma 2013-2017 Table Representative Insomnia Drugs Product One of Johnson & Johnson Table Representative Insomnia Drugs Product Two of Johnson & Johnson Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Insomnia Drugs Product One of Juste Table Representative Insomnia Drugs Product Two of Juste Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Juste 2013-2017 Table Representative Insomnia Drugs Product One of Meda Table Representative Insomnia Drugs Product Two of Meda Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Meda 2013-2017 Table Representative Insomnia Drugs Product One of Pernix Therapeutics Table Representative Insomnia Drugs Product Two of Pernix Therapeutics Table Insomnia Drugs Sales, Revenue, Price and Gross Margin of Pernix Therapeutics 2013-2017